DURECT (DRRX) News Today $1.92 +0.02 (+1.05%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DRRX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period DURECT Corporation Stock (DRRX) Opinions on Potential Acquisition by Bausch Health4 hours ago | quiverquant.comQDURECT Corporation (NASDAQ:DRRX) Sees Significant Drop in Short InterestAugust 20 at 7:24 PM | marketbeat.comDURECT (NASDAQ:DRRX) Stock Price Passes Above 200 Day Moving Average - Here's What HappenedAugust 20 at 3:20 AM | marketbeat.comDURECT (NASDAQ:DRRX) Releases Earnings Results, Beats Expectations By $0.06 EPSAugust 14, 2025 | marketbeat.comDurect, Bausch Health merger expected to close in Q3August 12, 2025 | msn.comDurect options imply 6.9% move in share price post-earningsAugust 12, 2025 | msn.comDURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on ...August 12, 2025 | gurufocus.comDURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch HealthAugust 12, 2025 | prnewswire.comDalton Investments Inc. Has $411,000 Holdings in DURECT Corporation (NASDAQ:DRRX)August 12, 2025 | marketbeat.comDURECT (NASDAQ:DRRX) Stock Passes Above 200-Day Moving Average - Time to Sell?August 10, 2025 | marketbeat.comBausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease TreatmentAugust 9, 2025 | insidermonkey.comBausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease TreatmentAugust 8, 2025 | msn.comDurect Extends Tender Offer Deadline in MergerAugust 8, 2025 | tipranks.comDURECT (DRRX) Projected to Post Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.comDURECT (NASDAQ:DRRX) Stock Price Passes Above Two Hundred Day Moving Average - Should You Sell?August 2, 2025 | marketbeat.com$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of DURECT Corporation (NASDAQ: DRRX)July 31, 2025 | globenewswire.comBausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT BuyoutJuly 29, 2025 | benzinga.comDRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to ShareholdersJuly 29, 2025 | tmcnet.comShareholder Alert: The Ademi Firm Investigates Whether DURECT Corporation Is Obtaining a Fair Price for Its Public ShareholdersJuly 29, 2025 | tmcnet.comBausch Health stock rises, Durect flies after acquisition dealJuly 29, 2025 | za.investing.comDurect Merges with Bausch Health for $1.75/ShareJuly 29, 2025 | tipranks.comBausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver DiseaseJuly 29, 2025 | prnewswire.comDURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 13, 2025 | prnewswire.comOppenheimer Sticks to Its Buy Rating for Durect (DRRX)March 30, 2025 | markets.businessinsider.comHere's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn SituationMarch 28, 2025 | finance.yahoo.comDURECT Corporation (NASDAQ:DRRX) Q4 2024 Earnings Call TranscriptMarch 28, 2025 | msn.comDURECT outlines $20M Phase 3 trial for larsucosterol in alcohol-associated hepatitisMarch 27, 2025 | msn.comDURECT Corporation (DRRX) Q4 2024 Earnings Call TranscriptMarch 26, 2025 | seekingalpha.comDURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 26, 2025 | prnewswire.comDURECT Q4 2024 Earnings PreviewMarch 25, 2025 | msn.comDURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business UpdateMarch 19, 2025 | prnewswire.comDurect Corporation Announces Board Member’s RetirementFebruary 21, 2025 | tipranks.comDURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | prnewswire.comH.C. Wainwright views Durect as significant ‘going concern’ riskJanuary 30, 2025 | markets.businessinsider.comDURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM EvidenceJanuary 28, 2025 | prnewswire.comOppenheimer Remains a Buy on Durect (DRRX)November 27, 2024 | markets.businessinsider.comDurect announces sale of Alzet line of osmotic pumps to LIC for $17.5MNovember 26, 2024 | markets.businessinsider.comDurect (DRRX) Gets a Buy from Northland SecuritiesNovember 26, 2024 | markets.businessinsider.comDURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 MillionNovember 25, 2024 | prnewswire.comDURECT Corporation (NASDAQ:DRRX) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | msn.comDURECT Corporation (DRRX) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comDURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 13, 2024 | prnewswire.comAn Overview of Durect's EarningsNovember 13, 2024 | benzinga.comDURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business UpdateNovember 6, 2024 | prnewswire.comDURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024October 17, 2024 | prnewswire.comDurect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Advances Amid ...October 9, 2024 | finance.yahoo.comDURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated HepatitisSeptember 25, 2024 | prnewswire.comDURECT Corporation to Present at the H.C. Wainwright Global Investment ConferenceSeptember 4, 2024 | prnewswire.comDRRX Apr 2025 2.000 putAugust 29, 2024 | ca.finance.yahoo.comDRRX Apr 2025 2.000 callAugust 29, 2024 | ca.finance.yahoo.com Get DURECT News Delivered to You Automatically Sign up to receive the latest news and ratings for DRRX and its competitors with MarketBeat's FREE daily newsletter. Email Address DRRX Media Mentions By Week DRRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRRX News Sentiment▼0.530.54▲Average Medical News Sentiment DRRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRRX Articles This Week▼31▲DRRX Articles Average Week Get DURECT News Delivered to You Automatically Sign up to receive the latest news and ratings for DRRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SGMT News Today SOPH News Today AARD News Today FENC News Today TLSA News Today GALT News Today ALEC News Today TVRD News Today MNPR News Today CRGX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRRX) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DURECT Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share DURECT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access